QuiaPEG Pharmaceuticals Holding AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2021-01-07 | QuiaPEG Pharmaceuticals Holding AB | Marcus Bosson | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 20 000 | 1,68 | SEK | 33 600 | 2021-01-06 |
| 2021-01-07 | QuiaPEG Pharmaceuticals Holding AB | Marcus Bosson | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 26 455 | 1,66 | SEK | 43 915,3 | 2021-01-03 |
| 2021-01-07 | QuiaPEG Pharmaceuticals Holding AB | Marcus Bosson | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 30 000 | 1,69 | SEK | 50 700 | 2021-01-06 |
| 2021-01-07 | QuiaPEG Pharmaceuticals Holding AB | Marcus Bosson | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 73 545 | 1,535 | SEK | 112 891,575 | 2020-12-29 |
| 2021-01-25 | QuiaPEG Pharmaceuticals Holding AB | Mats Nilsson Bernitz | Member of the Board of Directors | Exercise decrease | 14 285 | 1,2 | SEK | 17 142 | 2021-01-24 |
| 2021-01-25 | QuiaPEG Pharmaceuticals Holding AB | Mats Nilsson | Member of the Board of Directors | Exercise increase | 14 285 | 1,2 | SEK | 17 142 | 2021-01-24 |
| 2021-02-09 | QuiaPEG Pharmaceuticals Holding AB | Hans Johan Albert von Kantzow | Member of the Board of Directors | Exercise decrease | 250 000 | 1,2 | SEK | 300 000 | 2021-02-08 |
| 2021-02-09 | QuiaPEG Pharmaceuticals Holding AB | Hans Johan Albert von Kantzow | Member of the Board of Directors | Exercise increase | 250 000 | 1,2 | SEK | 300 000 | 2021-02-08 |
| 2021-02-09 | QuiaPEG Pharmaceuticals Holding AB | Johan von Kantzow | Member of the Board of Directors | Exercise decrease | 50 000 | 1,2 | SEK | 60 000 | 2021-02-08 |
| 2021-02-09 | QuiaPEG Pharmaceuticals Holding AB | Johan von Kantzow | Member of the Board of Directors | Exercise increase | 50 000 | 1,2 | SEK | 60 000 | 2021-02-08 |
| 2021-02-09 | QuiaPEG Pharmaceuticals Holding AB | Johan von Kantzow | Member of the Board of Directors | Exercise decrease | 120 000 | 1,2 | SEK | 144 000 | 2021-02-08 |
| 2021-02-09 | QuiaPEG Pharmaceuticals Holding AB | Johan von Kantzow | Member of the Board of Directors | Exercise increase | 120 000 | 1,2 | SEK | 144 000 | 2021-02-08 |
| 2021-02-09 | QuiaPEG Pharmaceuticals Holding AB | Marcus Bosson | Chief Executive Officer (CEO)/Managing Directory | Exercise decrease | 57 500 | 1,2 | SEK | 69 000 | 2021-02-08 |
| 2021-02-09 | QuiaPEG Pharmaceuticals Holding AB | Marcus Bosson | Chief Executive Officer (CEO)/Managing Directory | Exercise increase | 57 500 | 1,2 | SEK | 69 000 | 2021-02-08 |
| 2021-02-12 | QuiaPEG Pharmaceuticals Holding AB | Lars Gerhard Linzander | Member of the Board of Directors | Exercise decrease | 77 505 | 1,2 | SEK | 93 006 | 2021-02-10 |
| 2021-04-26 | QuiaPEG Pharmaceuticals Holding AB | Marcus Bosson | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 200 000 | 1,107 | SEK | 221 448,8 | 2021-04-22 |
| 2021-04-27 | QuiaPEG Pharmaceuticals Holding AB | Mats Nilsson Bernitz | Member of the Board of Directors | Subscription | 150 000 | 0,08 | SEK | 12 000 | 2021-04-22 |
| 2021-04-27 | QuiaPEG Pharmaceuticals Holding AB | Marcus Bosson | Chief Executive Officer (CEO)/Managing Directory | Subscription | 1 500 000 | 0,08 | SEK | 120 000 | 2021-04-22 |
| 2021-04-27 | QuiaPEG Pharmaceuticals Holding AB | Hans Johan Albert von Kantzow | Member of the Board of Directors | Subscription | 150 000 | 0,08 | SEK | 12 000 | 2021-04-22 |
| 2021-04-28 | QuiaPEG Pharmaceuticals Holding AB | Steen Kroyer | Chairman of the Board of Directors | Subscription | 150 000 | 0,08 | SEK | 12 000 | 2021-04-22 |